Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
32
days
Twenty‐year results of the randomized European Organization for Research and Treatment of Cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I–III breast cancer
Authors
Orit Kaidar‐Person; Caroline G. Weltens; Catherine Fortpied; Luc J. E. E. Scheijmans; Carine Y. Kirkove; Volker Budach; Karine Peignaux‐Casasnovas; Mariacarla Valli; Max Peters; Femke van der Leij; Sofia Rivera; Nicola Weidner; Desirée H. J. G. van den Bongard; Claudia Linsenmeier; Roxolyana Abdah‐Bortnyak; Shaymaa Hosni; Eveline Koiter; Antoine M. Engelen; Adinda Baten; Lydia Champezou; Alain Fourquet; Harry G. M. M. Bartelink; Henk Struikmans; Philip M. P. Poortmans; for the European Organization for Research and Treatment of Cancer Radiation Oncology and Breast Cancer GroupsShow moreShow less
Affiliations
1. Breast Radiation Unit Sheba Medical Center Ramat Gan Israel; 2. Gray Faculty of Medical and Health Sciences Tel Aviv University Tel Aviv Israel; 3. Department of Radiation Oncology University Hospitals Leuven Leuven Belgium; 4. Laboratory of Experimental Radiation Oncology Katholieke Universiteit te Leuven Leuven Belgium; 5. European Organization for Research and Treatment of Cancer Brussels Belgium; 6. Department of Radiation Oncology Institute Verbeeten Tilburg Netherlands; 7. Department of Radiation Oncology University Hospital Saint Luc Université Catholique de Louvain Brussels Belgium; 8. Department of Radiation Oncology Comprehensive Cancer Center Charite–University Medicine Berlin Corporate Member of Free University of Berlin and Humboldt University of Berlin BE Berlin Germany; 9. Radiation Oncology Vosspalais BE Berlin Germany; 10. Department of Radiation Oncology Centre Georges François Leclerc Dijon France; 11. Department of Radiation Oncology Sant Anna Hospital Como Italy; 12. Department of Radiation Oncology Ospedale Valduce Como Italy; 13. Department of Radiation Oncology Radiotherapiegroep Deventer/Arnhem Netherlands; 14. Department of Radiation Oncology University Medical Centre Utrecht Utrecht Netherlands; 15. Department of Radiation Oncology Gustave Roussy Cancer Centre Villejuif France; 16. Department of Radiation Oncology University Hospital Tübingen Germany; 17. Department of Radiation Oncology Cancer Center Amsterdam Amsterdam University Medical Center University of Amsterdam Amsterdam Netherlands; 18. Department of Radiation Oncology University Hospital Zürich University of Zürich Zürich Switzerland; 19. Department of Radiation Oncology The Joseph Fishman Oncology Center Rambam Health Care Campus Haifa Israel; 20. Nottingham University Hospitals National Health Service Trust Nottingham UK; 21. Department of Radiation Oncology Medisch Spectrum Twente Enschede Netherlands; 22. Department of Radiation Oncology Institut Curie Paris France; 23. Department of Radiation Oncology Netherlands Cancer Institute Amsterdam Netherlands; 24. Department of Radiation Oncology Haaglanden Medical Center the Hague Leidschendam Netherlands; 25. Department of Radiation Oncology Iridium Netwerk Wilrijk‐Antwerp Belgium; 26. Faculty of Medicine and Health Sciences University of Antwerp Wilrijk‐Antwerp BelgiumShow moreShow less
93
days
Medullary thyroid carcinoma and RET molecular testing: A virtual tumor board on clinical decision‐making
Authors
Lucas Kallas‐Silva; Victor Alexandre dos Santos Valsecchi; Ana O. Hoff; Evelin Cavalcante Farias; Rui Monteiro de Barros Maciel; Rachel Riera; Laura Sterian Ward; Lucas Leite CunhaShow moreShow less
Affiliations
1. Laboratory of Molecular and Translational Endocrinology, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo São Paulo Brazil; 2. Evidence‐Based Medicine and Urgent Medicine Unit, Escola Paulista de Medicina Universidade Federal de São Paulo São Paulo São Paulo Brazil; 3. Instituto do Câncer do Estado de São Paulo Faculdade de Medicina da Universidade de São Paulo São Paulo São Paulo Brazil; 4. Hospital Sirio‐Libanes São Paulo Brazil; 5. School of Medical Sciences, University of Campinas‐UNICAMP Campinas São Paulo Brazil; 6. AC Camargo Cancer Center, São Paulo São Paulo São Paulo BrazilShow moreShow less
126
days
Nonpharmacologic interventions for managing distress, anxiety, and depression for patients with cancer and their family caregivers: A systematic review and meta‐analysis
Authors
Lisa C. Schiess; Lixin L. Song; Sabine Schädelin; Thomas Fürst; Corinne Urech; Christopher R. Friese; Maria C. KatapodiShow moreShow less
Affiliations
1. Department of Clinical Research University of Basel Basel Switzerland; 2. School of Nursing University of Texas at San Antonio San Antonio Texas USA; 3. Department of Clinical Research University Hospital Basel Basel Switzerland; 4. University Medical Library Basel University of Basel Basel Switzerland; 5. Department of Obstetrics and Gynecology University Hospital Basel Basel Switzerland; 6. School of Nursing and Rogel Cancer Center University of Michigan Ann Arbor Michigan USAShow moreShow less
85
days
Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review
Authors
Brittany L. Greene; Jonathan M. MarronShow moreShow less
Affiliations
1. Seattle Children’s Research Institute Seattle Washington USA; 2. Department of Pediatrics University of Washington Seattle Washington USA; 3. Department of Pediatrics Harvard Medical School Boston Massachusetts USA; 4. Dana‐Farber/Boston Children’s Cancer and Blood Disorders Center Boston Massachusetts USA; 5. Center for Bioethics Harvard Medical School Boston Massachusetts USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days